glaucoma research foundation logo in black
Search
Generic filters
Filter by Categories
Eye Health
Personal Stories
Facts & Stats
Lifestyle Tips
Eye Exams
Treatments
Q&A
Research Updates
News
[wpdreams_ajaxsearchlite]

Subscribe to Gleams Newsletter

The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.

Order the version of Gleams that works best for you.
(The print version is only available if you live in the US or Canada.)

"The Gleams newsletter is how I stay connected to the latest news and advancements in glaucoma research, and in the GRF mission to find a cure."
Sandra Dempsy
Patient Summit Attendee

Explore the current issue of Gleams:

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.

Gleams Archives

Click on a cover to view or download the PDF of that issue.

January 2022
Volume 39, Number 2

SEPTEMBER 2021
Volume 39, Number 1

May 2021
Volume 38, Number 3

January 2021
Volume 38, Number 2

September 2020
Volume 38, Number 1

May 2020
Volume 37, Number 3

January 2020
Volume 37, Number 2

September 2019
Volume 37, Number 1

back of mailing envelope. snail mail icon.

Print Subscription

(The printed edition of the Gleams newsletter is only available if you live in the United States or Canada)

Name(Required)
Address(Required)
This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.

folded paper airplane. email icon.

E-mail Subscription

Name
This field is for validation purposes and should be left unchanged.

You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.